Comments
Commented by Armin Schulz on May 19th, 2025 | 07:00 CEST
Palantir, Credissential, D-Wave Quantum – How to harness the USD 1.4 trillion tsunami
The global tech landscape is on the verge of a historic transformation. An unprecedented capital influx of USD 1.4 trillion from the United Arab Emirates is flooding key industries of the future – AI, digital infrastructure, and quantum computing in the US. As nations battle for supremacy, hyperscale markets are emerging that are revolutionizing startups and corporations alike. Industries from energy to fintech are benefiting from unprecedented investments in computing power, digitalization, and data ecosystems. But who stands to gain? The answer lies in companies that strategically combine algorithms, security, digital business processes, and quantum leaps - and are rewriting the rules of value creation. Three names stand out: Palantir, Credissential, and D-Wave Quantum.
Read
Commented by Mario Hose on May 16th, 2025 | 14:00 CEST
Save the date and register now for free: From the raw materials boom to the AI revolution: Leading companies from five continents will present future opportunities on May 21, 2025, at the 15th International Investment Forum (IIF)
If you want to understand the trends of tomorrow, you need to hear directly from the people shaping them today. The 15th International Investment Forum (IIF) gives you that opportunity: On May 21, 2025, CEOs, investors, and thought leaders from across the globe will gather online to share insights from key sectors like industry, defense, mining, cleantech, biotech, AI, and more. In live presentations and interactive discussions, companies such as Germany's CENIT AG, Canada's First Phosphate Corp., dynaCert, Desert Gold, and Australia's Manuka Resources will provide exclusive insights into their strategies. The digital conference will be moderated by Stockhouse media star Lyndsay Malchuk, who is well-known for her incisive interviews. Why should you attend this event?
Read
Commented by André Will-Laudien on May 15th, 2025 | 07:15 CEST
100% buying frenzy at Palantir, investors look to D-Wave, European Lithium, and SMCI
First the sell-off, then a new high for the year. Investors can speculate about which of the recent erratic movements was the "right" one. A 20% correction in response to unresolved tariff claims was followed by a 30% rally to new highs of over 23,900 points on the DAX 40 index. The NASDAQ saw an even sharper correction, with tech stock Palantir halving in value before doubling again within four weeks. In between, Q1 figures were released that, in truth, merely met expectations. SMCI and D-Wave Quantum are now back in the spotlight due to their high beta. For those focusing on Greenland and strategic metals, European Lithium is worth a closer look. We help with the analysis.
Read
Commented by Armin Schulz on May 15th, 2025 | 07:10 CEST
Exploding profits? BYD's exports, Power Metallic Mines' drilling, Mercedes-Benz's tariff tactics
The mobility transition is accelerating, but the road to an electric future is fraught with dynamics and dilemmas. While global demand for electric vehicles is exploding, shortages of key raw materials such as nickel, copper, lithium, and cobalt threaten to slow down ambitions. Innovations in recycling, alternative materials, and ethical sourcing are becoming a decisive competitive advantage. At the same time, new technologies and government subsidies are pushing the market into an era full of opportunities. Three players are at the center of this upheaval: BYD as a battery pioneer, Power Metallic Mines as a raw material supplier, and Mercedes-Benz as a premium manufacturer, who are jointly rewriting the rules of the green revolution.
Read
Commented by Nico Popp on May 15th, 2025 | 07:05 CEST
Stable earnings – These cloud providers make portfolios robust: Apple, Spotify, MiMedia Holdings
Customers come and go. Restaurants have to win over their clientele anew each time. But it is different with digital subscriptions: we are willing to pay for our daily dose of music or our photo archive in the cloud. Even when prices rise, many customers are reluctant to switch to the competition. For companies like Apple, Spotify, and MiMedia Holdings, this creates the ideal conditions for stable earnings and future growth. We take a closer look at the three companies and explain how investors can seize opportunities.
Read
Commented by Fabian Lorenz on May 15th, 2025 | 07:00 CEST
Another 150%+ with Almonty stock? US defense industry and NASDAQ listing drive revaluation of the tungsten gem!
The revaluation of Almonty shares is progressing excellently and gaining new momentum. After rising over 150% within six months, the tungsten gem has consolidated healthily in recent weeks. However, there are good reasons to expect further price increases: China is using tungsten as a weapon in the geopolitical power struggle. The latest major order for Almonty from the US shows how urgently defense companies – but also other key industries – need this critical metal. An upcoming NASDAQ listing is expected to drive the share price and could pave the way for an anchor investor or even lead to a takeover. Analysts consider the fair value of Almonty shares well above the current level.
Read
Commented by Armin Schulz on May 14th, 2025 | 07:00 CEST
Patents, partnerships & tumor strategies: How Novo Nordisk, BioNxt Solutions, and BioNTech are securing tomorrow's profits
The global pharmaceutical industry, once the epitome of stable investments, is undergoing radical change. While protectionist trade barriers are disrupting supply chains and causing stock market prices to plummet, companies are forecasting growth for the biotech and pharmaceutical industries, according to the industry study "Life Sciences Executives Flash Report." The crisis is turning out to be a laboratory of opportunities – those who prioritize digital therapies, mRNA technologies, or sustainable production models now could emerge as winners in a reorganized market. But which strategies are convincing? We take a closer look at Novo Nordisk, BioNxt Solutions, and BioNTech.
Read
Commented by André Will-Laudien on May 13th, 2025 | 07:20 CEST
Defense out - Time to buy commodities! Hensoldt, Globex Mining, Barrick, Mutares, and Steyr
That is how quickly market darlings can fall out of favor. Just last week, Rheinmetall & Co. were hitting record highs, but as of Monday, the euphoria came to a sudden halt. Trump agreed with China on lower tariffs, and Volodymyr Zelenskyy will travel to Turkey on Thursday to sit down with Russia's aggressor, Vladimir Putin. At the moment, this is still hard to believe. For the capital markets, however, this means a shift: out of defense and into high-tech and automotive stocks, the biggest winners of recent hours. The whole thing could be seen as a healthy rotation, as the major indices are at record levels, while tech and automotive stocks have corrected significantly in recent weeks. Once again, the cards are being reshuffled. For Globex Mining, the setback is suitable for medium-term follow-up purchases.
Read
Commented by Fabian Lorenz on May 13th, 2025 | 07:15 CEST
Stocks are taking off! Nel, RENK, Walmart partner MiMedia! Is the tariff chaos coming to an end?
Will MiMedia's stock break through resistance and shoot to a new all-time high? The chances are good, as the cloud insider tip has navigated the tariff chaos of recent weeks surprisingly well. Now, the Company is set to scale up in Latin America with retail giant Walmart. With gross margins of 80% and above, the upside is substantial. Could new momentum come from the CEO soon? Things are already heating up at Renk - tomorrow's update will be crucial. Can the high-flyer's order backlog and outlook convince investors? Analysts remain cautious, and the potential downside for the stock should not be underestimated. And what is Nel doing? For shareholders, it is a rollercoaster once again. An order cancellation is followed by new hopes that the EU might completely cut off the Russian gas tap.
Read
Commented by Nico Popp on May 13th, 2025 | 07:10 CEST
The fight against cancer as a billion-dollar opportunity: BioNTech, Merck, and Vidac Pharma
Cancer is the scourge of our time. However, significant progress has already been made in recent years. In addition to significantly improved traditional therapies, individualized treatment approaches such as immunotherapy are repeatedly proving successful in curing patients. This trend is set to continue. Experts such as the investors at Candriam and market researchers at Spherical Insights foresee enormous growth – the market for cancer drugs could see double-digit annual growth by the 2030s. Market leaders such as BioNTech and Merck, as well as insider tips like Vidac Pharma, stand to benefit.
Read